Prognosis after cystectomy not affected by smoking

October 15, 2012
Prognosis after cystectomy not affected by smoking
Despite the link between cigarette smoking and the development of bladder cancer, the prognosis of people with bladder cancer after undergoing a cystectomy is not affected by cigarette smoking, according to research published online Oct. 8 in Urology.

(HealthDay)—Despite the link between cigarette smoking and the development of bladder cancer, the prognosis of people with bladder cancer after undergoing a cystectomy is not affected by cigarette smoking, according to research published online Oct. 8 in Urology.

In an effort to determine the effect of cigarette smoking on recurrence-free, cancer-specific, and overall survival, Chunwoo Lee, M.D., of the Asan Medical Center in Seoul, , and colleagues conducted a study involving 602 patients who had undergone radical cystectomy for bladder cancer.

The researchers found that, overall, 340 people had smoked and 159 were current smokers. For smokers and nonsmokers, the five-year recurrence-free survival rates were 62.1 and 56.8 percent, respectively. The five-year cancer-specific were 67.3 and 63.9 percent for smokers and nonsmokers, respectively. Finally, the five-year overall survival rate was 63.0 percent for smokers and 58.8 percent for nonsmokers. None of these between-group differences were statistically significant.

"The results of the present study suggest that smoking history is not a significant for the survival of operable patients with after radical cystectomy," the authors write. "However, it was not possible to ascertain whether smoking and the ensuing effects precluded some patients from undergoing radical cystectomy to begin with."

Explore further: Improved radical surgery techniques provide positive outcomes for bladder cancer patients

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Improved radical surgery techniques provide positive outcomes for bladder cancer patients

August 8, 2011
Bladder cancer patients who have radical surgery at university hospitals can benefit from excellent local control of the disease, acceptable clinical outcomes and low death rates, according to research in the August issue ...

Cigarette smoking implicated in half of bladder cancers in women

August 16, 2011
Current cigarette smokers have a higher risk of bladder cancer than previously reported, and the risk in women is now comparable to that in men, according to a study by scientists from the National Cancer Institute (NCI), ...

Chemo - radiation best for bladder cancer, study finds

April 19, 2012
(HealthDay) -- The addition of two well-tolerated chemotherapy drugs to radiation therapy led to significantly longer survival rates among patients with muscle-invasive bladder cancer.

Accelerated chemotherapy given before surgery benefits patients with muscle-invasive bladder cancer

May 17, 2012
For some patients with muscle-invasive bladder cancer, treatment may begin before they undergo cystectomy, or surgical removal of the bladder. They may be advised by oncologists to receive chemotherapy before surgery. A large ...

Recommended for you

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

Computer program finds new uses for old drugs

November 16, 2017
Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, ...

Pharmacoscopy improves therapy for relapsed blood cancer in a first clinical trial

November 16, 2017
Researchers at CeMM and the Medical University of Vienna presented a preliminary report in The Lancet Hematology on the clinical impact of an integrated ex vivo approach called pharmacoscopy. The procedures measure single-cell ...

Wider sampling of tumor tissues may guide drug choice, improve outcomes

November 15, 2017
A new study focused on describing genetic variations within a primary tumor, differences between the primary and a metastatic branch of that tumor, and additional diversity found in tumor DNA in the blood stream could help ...

A new strategy for prevention of liver cancer development

November 14, 2017
Primary liver cancer is now the second leading cause of cancer-related death worldwide, and its incidences and mortality are increasing rapidly in the United Stated. In late stages of the malignancy, there are no effective ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.